New Label For Evicel Fibrin Sealant Could Boost Omrix/Ethicon Market Share
This article was originally published in The Gray Sheet
Executive Summary
Omrix Biopharmaceuticals plans with the help of marketing partner Johnson & Johnson/Ethicon to take a larger share of the U.S. hemostasis market now that its Evicel fibrin sealant is approved for all types of surgery